查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878819

偏頭痛治療設備市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、部位、產品類型、療法、配銷通路、最終用戶、地區和競爭格局分類，2020-2030年預測

Migraine Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Site, By Product Type, By Therapy, By Distribution Channel, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球偏頭痛治療設備市場規模為7.4964億美元，預計到2030年將以8.54%的複合年成長率成長至12.2572億美元。該市場涵蓋旨在緩解或預防偏頭痛的專用醫療器械，主要採用神經刺激等非藥物療法。推動該市場成長的關鍵因素是全球偏頭痛盛行率的不斷上升，從而需要有效的治療方案。

市場概覽
預測期 2026-2030
2024年市場規模 7.4964億美元
2030年市場規模 12.2572億美元
2025-2030年複合年成長率 8.54%
成長最快的細分市場 居家照護
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球偏頭痛治療設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（體外三叉神經刺激（e-TNS）裝置、單脈衝經顱磁刺激器（sTMS）、gammaCore非侵入式迷走神經刺激器、其他）
    • 依使用地點（手持式、頭戴式、其他）
    • 依產品類型（處方藥、非處方藥）
    • 依治療方法（急性治療、預防治療）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按最終使用者（醫院和診所、家庭護理、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美偏頭痛治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲偏頭痛治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區偏頭痛治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲偏頭痛治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲偏頭痛治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球偏頭痛治療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Theranica Bio-Electronics Ltd.
  • CEFALY Technology SPRL
  • ElectroCore, Inc.
  • eNeura Inc.
  • Neurolief Ltd.
  • Cirrus Healthcare Products LLC
  • Neuros Medical Inc.
  • Salvia BioElectronics BV
  • Theranica Bio-Electronics Ltd.
  • Dr Reddy's Laboratories Ltd.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 8224

The Global Migraine Treatment Devices Market, valued at USD 749.64 Million in 2024, is projected to experience a CAGR of 8.54% to reach USD 1225.72 Million by 2030. The Global Migraine Treatment Devices Market encompasses specialized medical instruments designed to alleviate or prevent migraine headaches, primarily employing non-pharmacological approaches such as neurostimulation. A key driver for this market is the increasing global prevalence of migraine disorders, necessitating effective management solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 749.64 Million
Market Size 2030USD 1225.72 Million
CAGR 2025-20308.54%
Fastest Growing SegmentHomecare
Largest MarketNorth America

Key Market Drivers

The increasing global migraine prevalence constitutes a primary driver for the migraine treatment devices market, generating a substantial and expanding patient demographic in need of effective therapeutic options. Migraine, a debilitating neurological disorder, profoundly impacts quality of life and productivity, prompting individuals to seek diverse management solutions. The rising incidence globally underscores an urgent demand for innovative and accessible treatments, including non-pharmacological device-based therapies. According to 'The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region' published in Pain Ther. , December 2024, the global prevalence of migraine reached 1.16 billion cases in 2021, illustrating the immense number of individuals affected. This extensive burden necessitates the adoption of varied treatment modalities, fueling the market for specialized devices.

Key Market Challenges

A significant challenge impeding the growth of the Global Migraine Treatment Devices Market is the limited reimbursement coverage for these specialized instruments in various regions. This directly impacts market expansion by restricting patient access and hindering affordability. When innovative non-pharmacological migraine therapies, such as neurostimulation devices, lack comprehensive insurance coverage, patients often face substantial out-of-pocket costs. This financial burden can deter individuals from adopting these treatments, even when clinically appropriate.

Key Market Trends

The Global Migraine Treatment Devices Market is being significantly shaped by two distinct, influential trends. The first involves a growing patient preference for non-invasive devices. Patients increasingly seek therapeutic options that circumvent the side effects and complexities often associated with pharmacological treatments. This shift fosters demand for user-friendly, non-pharmacological alternatives for migraine management. According to MedTech Europe, the European medical device market recorded a growth rate of 2.4% in 2023, reflecting a broader acceptance and integration of diverse medical devices, including non-invasive options, into patient care. This preference is further demonstrated by real-world data, where 64.2% of school-aged participants effectively managed their migraine symptoms using the Nerivio REN wearable, a discreet, non-drug treatment, as reported by Theranica in December 2024. This indicates a strong inclination towards devices that offer effective relief without medication.

Key Market Players

  • Theranica Bio-Electronics Ltd.
  • CEFALY Technology SPRL
  • ElectroCore, Inc.
  • eNeura Inc.
  • Neurolief Ltd.
  • Cirrus Healthcare Products LLC
  • Neuros Medical Inc.
  • Salvia BioElectronics B.V.
  • Theranica Bio-Electronics Ltd.
  • Dr Reddy's Laboratories Ltd.

Report Scope:

In this report, the Global Migraine Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Migraine Treatment Devices Market, By Type:

  • External Trigeminal Nerve Stimulation (e-TNS) Device
  • Single Pulse Transcranial Magnetic Stimulator (sTMS)
  • gammaCore Non-Invasive Vagus Nerve Stimulator
  • Others

Migraine Treatment Devices Market, By Site:

  • Handheld
  • Headband
  • Others

Migraine Treatment Devices Market, By Product Type:

  • Prescription
  • Over The Counter

Migraine Treatment Devices Market, By Therapy:

  • Acute Therapy
  • Preventive Therapy

Migraine Treatment Devices Market, By Distribution Channel:

  • Hospital Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Migraine Treatment Devices Market, By End User:

  • Hospitals & Clinics
  • Homecare
  • Others

Migraine Treatment Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Migraine Treatment Devices Market.

Available Customizations:

Global Migraine Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Migraine Treatment Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (External Trigeminal Nerve Stimulation (e-TNS) Device, Single Pulse Transcranial Magnetic Stimulator (sTMS), gammaCore Non-Invasive Vagus Nerve Stimulator, Others)
    • 5.2.2. By Site (Handheld, Headband, Others)
    • 5.2.3. By Product Type (Prescription, Over The Counter)
    • 5.2.4. By Therapy (Acute Therapy, Preventive Therapy)
    • 5.2.5. By Distribution Channel (Hospital Based Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.6. By End User (Hospitals & Clinics, Homecare, Others)
    • 5.2.7. By Region
    • 5.2.8. By Company (2024)
  • 5.3. Market Map

6. North America Migraine Treatment Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Site
    • 6.2.3. By Product Type
    • 6.2.4. By Therapy
    • 6.2.5. By Distribution Channel
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Migraine Treatment Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Site
        • 6.3.1.2.3. By Product Type
        • 6.3.1.2.4. By Therapy
        • 6.3.1.2.5. By Distribution Channel
        • 6.3.1.2.6. By End User
    • 6.3.2. Canada Migraine Treatment Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Site
        • 6.3.2.2.3. By Product Type
        • 6.3.2.2.4. By Therapy
        • 6.3.2.2.5. By Distribution Channel
        • 6.3.2.2.6. By End User
    • 6.3.3. Mexico Migraine Treatment Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Site
        • 6.3.3.2.3. By Product Type
        • 6.3.3.2.4. By Therapy
        • 6.3.3.2.5. By Distribution Channel
        • 6.3.3.2.6. By End User

7. Europe Migraine Treatment Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Site
    • 7.2.3. By Product Type
    • 7.2.4. By Therapy
    • 7.2.5. By Distribution Channel
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Migraine Treatment Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Site
        • 7.3.1.2.3. By Product Type
        • 7.3.1.2.4. By Therapy
        • 7.3.1.2.5. By Distribution Channel
        • 7.3.1.2.6. By End User
    • 7.3.2. France Migraine Treatment Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Site
        • 7.3.2.2.3. By Product Type
        • 7.3.2.2.4. By Therapy
        • 7.3.2.2.5. By Distribution Channel
        • 7.3.2.2.6. By End User
    • 7.3.3. United Kingdom Migraine Treatment Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Site
        • 7.3.3.2.3. By Product Type
        • 7.3.3.2.4. By Therapy
        • 7.3.3.2.5. By Distribution Channel
        • 7.3.3.2.6. By End User
    • 7.3.4. Italy Migraine Treatment Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Site
        • 7.3.4.2.3. By Product Type
        • 7.3.4.2.4. By Therapy
        • 7.3.4.2.5. By Distribution Channel
        • 7.3.4.2.6. By End User
    • 7.3.5. Spain Migraine Treatment Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Site
        • 7.3.5.2.3. By Product Type
        • 7.3.5.2.4. By Therapy
        • 7.3.5.2.5. By Distribution Channel
        • 7.3.5.2.6. By End User

8. Asia Pacific Migraine Treatment Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Site
    • 8.2.3. By Product Type
    • 8.2.4. By Therapy
    • 8.2.5. By Distribution Channel
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Migraine Treatment Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Site
        • 8.3.1.2.3. By Product Type
        • 8.3.1.2.4. By Therapy
        • 8.3.1.2.5. By Distribution Channel
        • 8.3.1.2.6. By End User
    • 8.3.2. India Migraine Treatment Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Site
        • 8.3.2.2.3. By Product Type
        • 8.3.2.2.4. By Therapy
        • 8.3.2.2.5. By Distribution Channel
        • 8.3.2.2.6. By End User
    • 8.3.3. Japan Migraine Treatment Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Site
        • 8.3.3.2.3. By Product Type
        • 8.3.3.2.4. By Therapy
        • 8.3.3.2.5. By Distribution Channel
        • 8.3.3.2.6. By End User
    • 8.3.4. South Korea Migraine Treatment Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Site
        • 8.3.4.2.3. By Product Type
        • 8.3.4.2.4. By Therapy
        • 8.3.4.2.5. By Distribution Channel
        • 8.3.4.2.6. By End User
    • 8.3.5. Australia Migraine Treatment Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Site
        • 8.3.5.2.3. By Product Type
        • 8.3.5.2.4. By Therapy
        • 8.3.5.2.5. By Distribution Channel
        • 8.3.5.2.6. By End User

9. Middle East & Africa Migraine Treatment Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Site
    • 9.2.3. By Product Type
    • 9.2.4. By Therapy
    • 9.2.5. By Distribution Channel
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Migraine Treatment Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Site
        • 9.3.1.2.3. By Product Type
        • 9.3.1.2.4. By Therapy
        • 9.3.1.2.5. By Distribution Channel
        • 9.3.1.2.6. By End User
    • 9.3.2. UAE Migraine Treatment Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Site
        • 9.3.2.2.3. By Product Type
        • 9.3.2.2.4. By Therapy
        • 9.3.2.2.5. By Distribution Channel
        • 9.3.2.2.6. By End User
    • 9.3.3. South Africa Migraine Treatment Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Site
        • 9.3.3.2.3. By Product Type
        • 9.3.3.2.4. By Therapy
        • 9.3.3.2.5. By Distribution Channel
        • 9.3.3.2.6. By End User

10. South America Migraine Treatment Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Site
    • 10.2.3. By Product Type
    • 10.2.4. By Therapy
    • 10.2.5. By Distribution Channel
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Migraine Treatment Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Site
        • 10.3.1.2.3. By Product Type
        • 10.3.1.2.4. By Therapy
        • 10.3.1.2.5. By Distribution Channel
        • 10.3.1.2.6. By End User
    • 10.3.2. Colombia Migraine Treatment Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Site
        • 10.3.2.2.3. By Product Type
        • 10.3.2.2.4. By Therapy
        • 10.3.2.2.5. By Distribution Channel
        • 10.3.2.2.6. By End User
    • 10.3.3. Argentina Migraine Treatment Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Site
        • 10.3.3.2.3. By Product Type
        • 10.3.3.2.4. By Therapy
        • 10.3.3.2.5. By Distribution Channel
        • 10.3.3.2.6. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Migraine Treatment Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Theranica Bio-Electronics Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. CEFALY Technology SPRL
  • 15.3. ElectroCore, Inc.
  • 15.4. eNeura Inc.
  • 15.5. Neurolief Ltd.
  • 15.6. Cirrus Healthcare Products LLC
  • 15.7. Neuros Medical Inc.
  • 15.8. Salvia BioElectronics B.V.
  • 15.9. Theranica Bio-Electronics Ltd.
  • 15.10. Dr Reddy's Laboratories Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer